Even after controlling for multiple factors, 3-year mortality was 15% higher in men.
The approach to treating breast cancer in men is largely the same as in women. However, large studies of treatments for men have been hard to come by, as the number of male breast cancer patients is small, even in large referral centers.
To compare outcomes between men and women with breast cancer, investigators conducted a retrospective cohort study involving 16,000 men (median age, 63.3 years) and 1.8 million women (median age, 59.9 years) in the National Cancer Database who were diagnosed with breast cancer from 2004 through 2014. Race, ethnicity, clinical characteristics, treatment, and accessibility to care were taken into account.
At median follow-up of 54.0 months for men and 60.5 months for women, overall survival (the primary outcome…
Reviewing Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)